To 1st announcement PDF - Asahi Kasei Bioprocess
PLANOVA WORKSHOP HAINAN Is., CHINA, 2015 TM August 20, 2014 Dear valued customer, Asahi Kasei Medical Co., Ltd. is pleased to announce that the PlanovaTM Workshop Hainan Is., China will take place on the following dates and venue. PlanovaTM Workshop Hainan Is., China Sanya Marriott Resort & Spa in Hainan Island, China 15 th January, 2015 In China, the Plasma derivatives and biopharmaceutical industry are growing strongly. And safety issue of those products has become one of the biggest concerns in the industry. In such circumstances, the need for virus removal filters is becoming greater and greater. PlanovaTM filters were launched in 1989 as the first filters developed specifically for removing viruses from biotherapeutics such as biopharmaceuticals and plasma derivatives. Planova filters have two decades of proven safety and reliability in the international biotherapeutic industry, including China. In this workshop, more than 10 presentations including examples of the use of Planova filters will be given. Therefore, this workshop is an excellent chance for attendees to exchange information with industry experts and become acquainted with Planova filters and related technical services. The provisional program is provided on the attached pages. You will receive further information such as programs, registration details, and accommodation in the 2nd announcement expected to be issued in October, 2014. We are looking forward to welcome you in Sanya in January. Yours Sincerely, Hiroto Kato General Manager Asahi Kasei Medical Co., Ltd. Bioprocess Division Provisional Schedule Wednesday, January 14, 2015 17:00- Registration and Welcome Cocktail 19:00- Welcome dinner Thursday, January 15, 2015 8:50 - 9:00 9:00 - 12:00 12:00 - 13:00 13:00 - 17:00 17:00 19:00 - Opening Remarks Sessions Lunch Sessions Closing Remarks Dinner Friday, January 16, 2015 Breakfast, followed by check-out ( ★=Titles are tentative and subjected to change) ▼ Provisional Speakers and Presentations ▼ Sami Chtourou, Ph.D., Senior Vice President, Innovations and Scientific Affairs, LFB Biotechnologies, France State of the art of the IvIG manufacturing ▼ Eckhard Flechsig, Ph.D., Director Pathogen Safety, Biotest AG, Germany State of the art of the Coagulation factor and Mab Manufacturing ★ ▼ Rui Fu, Scientist, National Institutes for Food and Drug Control, China Viral clearance of Bio Products in China ▼ Albrecht Groener, Ph.D., Head Pathogen Safety, CSL Behring, Germany State of the art in approaches to ensure the pathogens safety of Plasma derived products in industry perspective ★ ▼ Jifeng Hou, Head of Division of Blood Products, National Institutes for Food and Drug Control, China Blood Products Safety and Regulation in China ▼ Joseph V. Hughes, Ph.D., Chief Scientist for Virology, Vice President of Service Development, Wuxi Apptec, USA Validation of Virus Filtration steps ★ ▼ T homas Kreil, Ph.D., Associate Professor of Virology, Senior Director Global Pathogen Safety, Baxter BioScience, Austria Pathogen Safety of Biological Medicinal Products ▼ Hong Liang, Project Manager, Chengdu Rongsheng Pharmaceuticals Co., Ltd., China IvIG manufacturing with 35N and evaluation of BioEX for IvIG ★ ▼ Zhanjie Liu, Ph.D., Deputy Manager, Shanghai Representative Office of Bioprocess Division, Asahi Kasei Medical Co., Ltd., Japan Planova Filters -Virus Removal from Bio-therapeutic Products- ▼ Shan Ma, Head of Research and Development Division, Joint Ventrure Shandong Taibang Biological Products Co., Ltd., China BioEX application on IvIG product ★ Tomoyuki Miyabayashi, General Manager, Technical Marketing Department, Bioprocess Division, Asahi Kasei Medical Co., Ltd., Japan Asahi Development concept ★ For more information, please contact: Asahi Kasei Medical Co., Ltd. Bioprocess Division Mr. Kazuhiro Inoue +81-080-1117-6123 [email protected]
© Copyright 2024